Cargando…

Treating patients suffering from acute coronary syndrome with prasugrel, the Rotterdam experience

Detalles Bibliográficos
Autor principal:	de Winter, R. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2018
Materias:	Editor’s Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046656/ https://www.ncbi.nlm.nih.gov/pubmed/29934837 http://dx.doi.org/10.1007/s12471-018-1127-z

Ejemplares similares

Prasugrel for the treatment of patients with acute coronary syndrome
por: Marzot, Filippo, et al.
Publicado: (2009)

Influence of body size on platelet response to ticagrelor and prasugrel in patients with acute coronary syndromes
por: Ndrepepa, Gjin, et al.
Publicado: (2021)

Anticoagulation and antiplatelet therapy in acute coronary syndromes: choosing between the Scylla of bleeding and the Charybdis of ischaemic events
por: de Winter, R. J.
Publicado: (2018)

Measuring hospital performance in the management of acute coronary syndromes
por: de Winter, R. J.
Publicado: (2014)

“Real‐World” Comparison of Prasugrel With Ticagrelor in Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention in the United States
por: Larmore, Cynthia, et al.
Publicado: (2015)

Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Norgard, Nicholas B, et al.
Publicado: (2009)

Treatment strategies and outcomes in patients with non-ST-elevation acute coronary syndrome in the Netherlands
por: Damman, P., et al.
Publicado: (2018)

Prasugrel-Based De-Escalation in Patients With Acute Coronary Syndrome According to Renal Function
por: Yun, Jun Pil, et al.
Publicado: (2023)

Impact of Prasugrel and Ticagrelor on Platelet Reactivity in Patients With Acute Coronary Syndrome: A Meta-Analysis
por: Dai, Lulu, et al.
Publicado: (2022)

Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
por: Koch, Tobias, et al.
Publicado: (2023)

Real‐World Evidence on Disparities on the Initiation of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome
por: Yildirim, Mustafa, et al.
Publicado: (2023)

Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy
por: Liu, Ping-Yen, et al.
Publicado: (2021)

Use of Clopidogrel, Prasugrel, or Ticagrelor and Patient Outcome after Acute Coronary Syndrome in Austria from 2015 to 2017
por: Rezaei, Safoura Sheikh, et al.
Publicado: (2020)

Changes in neutrophil-lymphocyte and platelet-lymphocyte ratios before and after percutaneous coronary intervention and their impact on the prognosis of patients with acute coronary syndrome
por: Souza Teixeira, Edenilson de, et al.
Publicado: (2023)

Zenker’s diverticulum: Rotterdam experience
por: Visser, L. J., et al.
Publicado: (2015)

One-year efficacy and safety of routine prasugrel in patients with acute coronary syndromes treated with percutaneous coronary intervention: results of the prospective rijnmond collective cardiology research study
por: Yetgin, T., et al.
Publicado: (2018)

Comparison of platelet reactivity between prasugrel and ticagrelor in patients with acute coronary syndrome: a meta-analysis
por: Wen, Mingxiang, et al.
Publicado: (2020)

Molecular imaging of coronary atherosclerosis; predictive of an acute myocardial infarction?
por: van der Wall, E. E.
Publicado: (2013)

The key role of palliative care in response to the COVID-19 tsunami of suffering
por: Radbruch, Lukas, et al.
Publicado: (2020)

De-escalation therapy after acute coronary syndrome: is it reasonable to switch from prasugrel (or ticagrelor) to clopidogrel early?
por: Masiero, Giulia, et al.
Publicado: (2020)

Comparison of lower loading dose of prasugrel with conventional loading dose of prasugrel in Indian patients undergoing percutaneous coronary interventions
por: Kumari, Priti, et al.
Publicado: (2018)

Ticagrelor after Acute Coronary Syndrome: One For All or Part of Personalized Medicine?
por: Akin, Ibrahim, et al.
Publicado: (2022)

Time Course of Ischemic and Bleeding Burden in Elderly Patients With Acute Coronary Syndromes Randomized to Low‐Dose Prasugrel or Clopidogrel
por: Crimi, Gabriele, et al.
Publicado: (2019)

Antiplatelet therapy in patients with acute coronary syndromes and thrombocytopaenia: awaiting for evidence
por: Liga, Riccardo, et al.
Publicado: (2021)

Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial
por: Murphy, Sabina A., et al.
Publicado: (2008)

Comparison of Clopidogrel With Prasugrel and Ticagrelor in Patients With Acute Coronary Syndrome: Clinical Outcomes From the National Cardiovascular Database ACTION Registry
por: Khayata, Mohamed, et al.
Publicado: (2017)

High Platelet Reactivity in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Randomised Controlled Trial Comparing Prasugrel and Clopidogrel
por: Geisler, Tobias, et al.
Publicado: (2015)

Prasugrel versus ticagrelor for acute coronary syndrome patients undergoing percutaneous coronary intervention: A critical appraisal of randomized controlled trials
por: Almas, Talal, et al.
Publicado: (2022)

Adoption of prasugrel into routine practice: rationale and design of the Rijnmond Collective Cardiology Research (CCR) study in percutaneous coronary intervention for acute coronary syndromes
por: Yetgin, T., et al.
Publicado: (2013)

Case Study: Ticagrelor in PLATO and Prasugrel in TRITON-TIMI 38 and TRILOGY-ACS Trials in Patients With Acute Coronary Syndromes
por: Husted, Steen, et al.
Publicado: (2016)

Coronary physiology revisited
por: Piek, J. J.
Publicado: (2017)

Experience with non-vitamin K antagonists in the Netherlands: stories from both sides of the desk
por: de Vries, T. A. C., et al.
Publicado: (2019)

Percutaneous coronary intervention for chronic total coronary occlusion: Do. Or do not. There is no try
por: Knaapen, P., et al.
Publicado: (2020)

I want it all, and I want it now
por: de Winter, R. J.
Publicado: (2020)

Renal denervation revisited; should we pay attention?
por: de Winter, R. J.
Publicado: (2022)

Tricuspid regurgitation: remembering ‘the forgotten valve’
por: de Winter, R. J.
Publicado: (2022)

Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel
por: Motovska, Zuzana, et al.
Publicado: (2009)

How the andrological sector suffered from the dramatic Covid 19 outbreak in Italy: supportive initiatives of the Italian Association of Andrology (SIA)
por: Rizzo, Michele, et al.
Publicado: (2020)

Comparative Effectiveness of Ticagrelor, Prasugrel, and Clopidogrel for Secondary Prophylaxis in Acute Coronary Syndrome: A Propensity Score‐Matched Cohort Study
por: Kumar, Arun, et al.
Publicado: (2022)

Prasugrel in critically ill patients
por: Schoergenhofer, Christian, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_68sa6m6gmnqd09hugqtlqsnh2v